SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-073892
Filing Date
2022-06-23
Accepted
2022-06-23 16:05:24
Documents
14
Period of Report
2022-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2219269d1_8k.htm   iXBRL 8-K 29436
2 EXHIBIT 10.1 tm2219269d1_ex10-1.htm EX-10.1 26574
3 EXHIBIT 10.2 tm2219269d1_ex10-2.htm EX-10.2 24477
  Complete submission text file 0001104659-22-073892.txt   266286

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vygr-20220622.xsd EX-101.SCH 3066
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20220622_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20220622_pre.xml EX-101.PRE 22617
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2219269d1_8k_htm.xml XML 3485
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 221035452
SIC: 2836 Biological Products, (No Diagnostic Substances)